Literature DB >> 17056530

Endogenous IL-1R1 signaling is critical for cognate CD4+ T cell help for induction of in vivo type 1 and type 2 antipolysaccharide and antiprotein Ig isotype responses to intact Streptococcus pneumoniae, but not to a soluble pneumococcal conjugate vaccine.

Quanyi Chen1, Goutam Sen, Clifford M Snapper.   

Abstract

MyD88(-/-) mice exhibit defective innate, diminished CD4(+) T cell-dependent (TD) type 1, but enhanced type 2, humoral immunity in response to intact Streptococcus pneumoniae (Pn). Because type 1 IL-1R (IL-1R1) signaling is MyD88 dependent, a role for endogenous IL-1 was determined. IL-1R1(-/-), in contrast to MyD88(-/-), mice exhibited relatively intact innate splenic cytokine expression in response to Pn. Nevertheless, IL-1R1(-/-), like MyD88(-/-), mice were more sensitive to killing with live Pn relative to wild-type controls. Although IL-1R1(-/-) mice elicited a normal T cell-independent IgM antipolysaccharide (PS) response to heat-killed Pn, the induction of PS- and protein-specific cognate, but not noncognate, TD type 1 and type 2 IgG isotypes were markedly reduced. Additionally, CD4(+) T cells from Pn-primed IL-1R1(-/-) mice failed to elicit IFN-gamma, IL-5, or IL-13 secretion upon restimulation with Pn in vitro, whereas MyD88(-/-) mice secreted normal levels of IFN-gamma and enhanced levels of IL-5 and IL-13. In contrast, IgG responses to a soluble, pneumococcal protein-PS conjugate, with or without adjuvant, showed little dependence on IL-1R1 and normal CD4(+) T cell priming. These data are the first to demonstrate a nonredundant role for endogenous IL-1 in TD induction of humoral immune responses to an intact pathogen, although not a pathogen-derived soluble conjugate, suggesting that antigenic context is a key determinant for IL-1 dependence. These data further suggest that IL-1 may be critical for preserving CD4(+) Th2 function in the presence, but not absence, of MyD88-dependent signaling via TLRs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056530     DOI: 10.4049/jimmunol.177.9.6044

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.

Authors:  Quanyi Chen; Jennifer L Cannons; James C Paton; Hisaya Akiba; Pamela L Schwartzberg; Clifford M Snapper
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation.

Authors:  Shlomo Z Ben-Sasson; Jane Hu-Li; Juan Quiel; Stephane Cauchetaux; Maya Ratner; Ilana Shapira; Charles A Dinarello; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

3.  Macrophages pulsed with Streptococcus pneumoniae elicit a T cell-dependent antibody response upon transfer into naive mice.

Authors:  Sam Vasilevsky; Jesus Colino; Roman Puliaev; David H Canaday; Clifford M Snapper
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

4.  B and CD4+ T-cell expression of TLR2 is critical for optimal induction of a T-cell-dependent humoral immune response to intact Streptococcus pneumoniae.

Authors:  Sam Vasilevsky; Gouri Chattopadhyay; Jesus Colino; Tze-Jou Yeh; Quanyi Chen; Goutam Sen; Clifford M Snapper
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

5.  Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.

Authors:  Jairam R Lingappa; Logan Dumitrescu; Shanta M Zimmer; Ruth Lynfield; Janet M McNicholl; Nancy E Messonnier; Cynthia G Whitney; Dana C Crawford
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

6.  Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity.

Authors:  Shanshan Xie; Laura Spelmink; Mario Codemo; Karthik Subramanian; Katrin Pütsep; Birgitta Henriques-Normark; Marie Olliver
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.